Skip to Main Content

Paper Details

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Nat Commun
77
2018
AR, ERG, FOXA1, GWAS tag SNPs, Prostate cancer, candidate variants, eQTL, low-penetrance, polygenic, promoter and enhancer elements, prostate, prostate cancer, prostate cancer risk loci, prostate cancer susceptibility loci, susceptibility regions, transcription factor-binding sites
Author NameAffiliation
Tokhir DadaevThe Institute of Cancer Research
Daniel LeongamornlertThe Institute of Cancer Research
Daniel LeongamornlertWellcome Trust Sanger Institute
Fredrick R SchumacherCase Western Reserve University
Fredrick R SchumacherSeidman Cancer Center, University Hospitals
Fredrick R SchumacherCase Western Reserve University
Fredrick R SchumacherSeidman Cancer Center, University Hospitals
Sonja I BerndtNational Cancer Institute
Mahbubl AhmedThe Institute of Cancer Research
Ian M ThompsonCHRISTUS Santa Rosa Hospital - Medical Center
Judith A ClementsAustralian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology
Judith A ClementsTranslational Research Institute
Gail P RisbridgerBiomedicine Discovery Institute, Monash University
Gail P RisbridgerPeter MacCallum Cancer Centre
Henrik Gr??nbergKarolinska Institute
Henrik Gr??nbergKarolinska Institute
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Johanna SchleutkerInstitute of Biomedicine, University of Turku
Johanna SchleutkerTurku University Hospital
Johanna SchleutkerInstitute of Biomedicine, University of Turku
Johanna SchleutkerTurku University Hospital
Demetrius AlbanesNational Cancer Institute
Stephanie J WeinsteinNational Cancer Institute
Catharine M L WestManchester NIHR Biomedical Research Centre, The Christie Hospital NHS Foundation Trust, University of Manchester
Alison M DunningUniversity of Cambridge
Lorelei A MucciHarvard School of Public Health
Edward L GiovannucciHarvard School of Public Health
Edward L GiovannucciHarvard School of Public Health
Gerald L AndrioleWashington University School of Medicine
David E NealAddenbrooke's Hospital, University of Cambridge
David E NealCancer Research UK Cambridge Research Institute
David E NealUniversity of Oxford
Freddie C HamdyUniversity of Oxford
Freddie C HamdyJohn Radcliffe Hospital, University of Oxford
Ruth C TravisUniversity of Oxford
Timothy J KeyUniversity of Oxford
Neil E FleshnerPrincess Margaret Cancer Centre
Antonio FinelliPrincess Margaret Cancer Centre
Sue A InglesKeck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Yong-Jie LuBarts Cancer Institute, Queen Mary University of London
Graham G Giles
Graham G GilesThe University of Melbourne
Kathryn L PenneyBrigham and Women's Hospital/Harvard Medical School
Meir J StampferBrigham and Women's Hospital/Harvard Medical School
Meir J StampferBrigham and Women's Hospital/Harvard Medical School
Janet L StanfordFred Hutchinson Cancer Research Center
Janet L StanfordSchool of Public Health, University of Washington
  • 1 - 50

Datasets